Snack Ingredients for Blood Sugar Control
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to examine how different snack ingredients affect blood sugar levels. Participants will consume snacks containing either honey or sugar, both alone and with almonds, to explore how these combinations impact glucose levels after eating. The researchers believe honey and almonds might help manage blood sugar while maintaining satiety. Women who are pre-menopausal and willing to eat these snacks, without major chronic illnesses like diabetes or heart disease, are ideal candidates for this trial. As an unphased trial, this study offers a unique opportunity to contribute to nutritional science and potentially improve dietary recommendations.
Will I have to stop taking my current medications?
The trial excludes individuals who are routinely taking medications known to affect glucose response, so you may need to stop such medications to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that honey is usually easy to digest and might cause smaller blood sugar spikes than regular sugar. Some studies suggest that honey can lead to smaller increases in blood sugar for people with type 2 diabetes, but results vary, and not all studies agree.
When combined with almonds, honey might help control blood sugar better. Studies have found that almonds can lower fasting blood sugar levels and improve overall blood sugar management.
The FDA considers table sugar, or sucrose, safe, and it is commonly used in foods. However, consuming large amounts of sucrose, especially in drinks, can increase the risk of developing type 2 diabetes.
Adding almonds to a diet that includes sucrose might also help with blood sugar control. Research suggests that almonds can improve blood sugar levels when part of a balanced diet.
Overall, both honey and sucrose are generally safe to eat. Including almonds might help with blood sugar management. Participants should consider this information when deciding whether to join the trial.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for blood sugar control because they explore natural snack ingredients like honey and almonds, which are not standard in current diabetes management. Unlike traditional medications that often involve synthetic drugs, these treatments use honey and sucrose, with and without almonds, to potentially regulate blood sugar levels. This approach could offer a more natural and dietary-based method for managing blood sugar, possibly with fewer side effects. Additionally, the use of continuous glucose monitoring allows for real-time tracking of blood sugar changes, providing valuable insights into how these ingredients impact glucose levels throughout the day.
What evidence suggests that this trial's treatments could be effective for blood sugar control?
Research shows that honey might help lower blood sugar levels. In studies with diabetic rats, honey significantly reduced blood sugar. In humans, results are mixed; some studies found a decrease in blood sugar, while others did not observe much change. This trial will evaluate the effects of honey and honey with almonds on blood sugar control. Research suggests that almonds may help control blood sugar, especially in people with prediabetes. Eating almonds with honey or sugar might manage blood sugar better than sugar alone, as almonds can reduce blood sugar spikes after meals. This trial will also assess the effects of sucrose and sucrose with almonds. However, more research is needed to understand the exact benefits of these combinations.16789
Who Is on the Research Team?
Mary Kable, PhD
Principal Investigator
USDA, ARS, Western Human Nutrition Research Center
Nancy Keim, PhD
Principal Investigator
USDA, ARS, Western Human Nutrition Research Center
Kevin Laugero, PhD
Principal Investigator
USDA, ARS, Western Human Nutrition Research Center
Are You a Good Fit for This Trial?
This trial is for pre-menopausal women without chronic diseases like heart or kidney disease, diabetes, thyroid issues needing medication, bowel diseases, or recent major surgeries. They must be willing to eat snacks with honey, sugar, and nuts but can't have nut allergies or a BMI <18.5 or >40.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants consume honey and nuts or sugar and nuts, with continuous glucose monitoring
Wash-out
A wash-out period between treatment phases
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Honey
- Honey plus almonds
- Sucrose
- Sucrose plus almonds
Trial Overview
The study compares the effects of two snacks on blood sugar levels: one snack combines honey with nuts and the other combines table sugar with nuts. The goal is to see if honey and nuts together better manage glucose after eating compared to just sugar and nuts.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Participants will be provided sucrose alone once each day for 3 days, then sucrose plus almonds for an additional 3 days while wearing a continuous glucose monitor. After a 14 day wash-out, participants will be provided honey alone once each day for 3 days, then honey plus almonds for an additional 3 days while wearing a continuous glucose monitor.
Participants will be provided honey alone once each day for 3 days, then honey plus almonds for an additional 3 days while wearing a continuous glucose monitor. After a 14 day wash-out, participants will be provided sucrose alone once each day for 3 days, then sucrose plus almonds for an additional 3 days while wearing a continuous glucose monitor.
Find a Clinic Near You
Who Is Running the Clinical Trial?
USDA, Western Human Nutrition Research Center
Lead Sponsor
National Honey Board
Collaborator
Published Research Related to This Trial
Citations
Honey and Diabetes: The Importance of Natural Simple ...
The honey-treated diabetic rats had significantly reduced blood glucose levels [8.8 (5.8) mmol/L; median (interquartile range)] compared with ...
Honey and diabetes mellitus: Obstacles and challenges
The authors reported that daily intake honey for three weeks efficiently decreased blood glucose level in alloxan induced diabetic rats. Honey resulted in ...
Effect of Natural Honey on Glycemic Control and ...
Eight weeks consumption of 50 g/day honey increased HbA1c and decreased waist circumference of patients with type 2 diabetes.
Glycemic response of honey and dates consumption
The mean blood glucose levels after honey ingestion were higher than that when the date was ingested and lower than that of the reference food.
A Review on the Protective Effects of Honey against ...
Honey intake reduces blood sugar levels and prevents excessive weight gain. It also improves lipid metabolism by reducing total cholesterol (TC), triglyceride ( ...
Honey and glycemic control: A systematic review
Honey's effect on blood glucose is controversial; some studies show reduction, others no change or increase. Limited human trials make a definite conclusion ...
Can People With Diabetes Have Honey?
Both raw and filtered honey can spike your glucose levels if you have diabetes, but honey still has a lower GI than white sugar. So raw honey, ...
A Comprehensive Review of the Effect of Honey on Human ...
Significantly lower increases in blood glucose levels have been observed in subjects with type II diabetes after ingestion of natural honey [21] and clover ...
The glycaemic index of Manuka honey
The glycemic index (GI) of five Manuka honey samples tested was in the moderate range, with values between 54 and 59.
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.